(Q46715554)

English

Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy

scientific article published in March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

1 reference

based on heuristic

inferred from title

author name string

Rhoden EL

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

Morgentaler A

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

publication date

1 March 2006

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

International Journal of Impotence Research

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

18

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

201-205

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

https://scigraph.springernature.com/pub.10.1038/sj.ijir.3901394

0 references

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

Prostate cancer after exogenous testosterone treatment for impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

The effect of parenteral testosterone replacement on prostate specific antigen in hypogonadal men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

Risks of testosterone-replacement therapy and recommendations for monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

21 January 2018

Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal evaluation of serum androgen levels in men with and without prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901394

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.IJIR.3901394

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16177827

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46715554&oldid=2127989029"